KRYS
Krystal Biotech, Inc.
+1.37 (+0.41%)338.04USD44.9K成交股數10.0B市值42.4本益比(近四季)22.7股價營收比+24.1%營收年增(近四季)2026-11-02下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 119M+24% | 116M+32% | 107M+28% | 97.8M+39% | 96.0M+112% | 88.2M+109% | 83.8M+880% | 70.3M | 45.3M | 42.1M | 8.6M | 0 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 14.5M | 15.3M | 14.8M | 14.6M | 14.4M | 14.3M | 13.5M | 15.6M | 11.0M | 11.4M | 10.6M | 12.1M |
| 銷售管理費用 | 39.9M | 41.0M | 41.4M | 37.6M | 35.1M | 32.6M | 28.7M | 27.6M | 26.1M | 24.7M | 23.7M | 25.9M |
| 營業利益 | 58.4M+48% | 53.7M+48% | 44.3M+97% | 41.4M+383% | 39.4M-689% | 36.3M+1016% | 22.5M-186% | 8.6M-123% | −6.7M | 3.2M | −26.0M | −38.0M |
| 營業利益率 | 49.0% | 46.1% | 41.3% | 42.3% | 41.0% | 41.1% | 26.8% | 12.2% | -14.8% | 7.7% | -303.8% | – |
| 稅後淨利 | 54.8M+43% | 55.9M+57% | 51.4M+89% | 79.4M+410% | 38.3M+4013% | 35.7M+311% | 27.2M-66% | 15.6M-147% | 932K | 8.7M | 80.7M | −33.2M |
| 淨利率 | 45.9% | 48.1% | 48.0% | 81.2% | 39.9% | 40.5% | 32.4% | 22.2% | 2.1% | 20.6% | 943.7% | – |
| 稀釋 EPS | 1.79+39% | 1.83+53% | 1.69+86% | 2.66+402% | 1.29+4200% | 1.20+97% | 0.91-67% | 0.53-142% | 0.03 | 0.61 | 2.79 | -1.25 |
| 稀釋股數 | 30.7M | 30.5M | 30.0M | 29.8M | 29.7M | 29.9M | 29.9M | 29.6M | 29.3M | 27.8M | 28.9M | 26.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 428M | 501M | 496M | 393M | 354M | 309M | 374M | 346M | 359M | 358M | 373M | 276M |
| 應收帳款 | 139M | 127M | 127M | 130M | 111M | 103M | 97.3M | 103M | 105M | 42.0M | 9.3M | – |
| 存貨 | 45.6M | 42.6M | 40.5M | 37.6M | 31.0M | 29.9M | 18.6M | 12.2M | 11.0M | 7.0M | 5.3M | – |
| 總資產 | 1.5B | 1.4B | 1.3B | 1.2B | 1.1B | 1.1B | 982M | 918M | 853M | 818M | 790M | 684M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 142M | 120M | 114M | 102M | 97.7M | 89.7M | 96.5M | 78.8M | 54.1M | 39.7M | 34.4M | 30.9M |
| 股東權益 | 1.4B | 1.3B | 1.2B | 1.1B | 1.0B | 985M | 886M | 839M | 799M | 779M | 756M | 653M |
| 負債比 | 9.4% | 8.6% | 8.6% | 8.2% | 8.6% | 8.4% | 9.8% | 8.6% | 6.3% | 4.9% | 4.4% | 4.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 80.4M+160% | – | – | – | 31.0M | – | – | 15.9M | – | – | – |
| 資本支出 | – | 7.1M | – | – | – | 6.2M | – | – | 1.3M | – | – | – |
| 自由現金流 | – | 73.2M+196% | – | – | – | 24.8M | – | – | 14.6M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 62.9% | – | – | – | 28.1% | – | – | 32.3% | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 389M | +33.9% | 205M | 52.6% | 6.84 | 189M |
| FY2024 | 291M | +473.0% | 89.2M | 30.7% | 3.00 | 119M |
| FY2023 | 50.7M | – | 10.9M | 21.6% | 0.39 | −101M |
| FY2022 | 0 | – | −140M | –% | -5.49 | −154M |
| FY2021 | 0 | – | −69.6M | –% | -3.13 | −116M |
| FY2020 | – | – | −32.2M | –% | -1.71 | −40.9M |
| FY2019 | – | – | −19.1M | –% | -1.20 | −25.1M |
| FY2018 | – | – | −10.9M | –% | -0.97 | −11.7M |